Macleods Pharmaceuticals Ltd. is a vertically integrated global pharmaceutical company. Foundation of Macleods was laid by visionary and enterprising individual, Dr. Rajendra Agarwal in 1986, when he ventured on his own to create a history in the Indian Pharmaceutical Industry by choosing Anti-TB as a focused area of operation and went on to make Macleods as one of the major global supplier of entire first line and second line Anti-TB drugs.

In the last two decades, Macleods recorded a quantum leap and emerged as a leading pharmaceutical major in India by augmenting its efforts with product diversification, expansion of manufacturing capacities, and emphasis on marketing and creating business opportunities through new launches.

Macleods derives its competitive edge from successful and strategic moves it has made in the area of world class manufacturing, R&D and global operations with the objective of delivering affordable and accessible medication that satisfies needs of all.

Macleods has gained a special reputation in Indian Pharma market because of unprecedented growth rate it has registered in the last few years. One of the top grosser in terms of new product launches, Macleods is recognized widely for its expertise in brand building with many of its brands featuring amongst top 300 brands of the industry.

Current decade has witnessed Macleods fortifying its presence in the segment of Anti-infective, Cardio-vascular, CNS, Respiratory inhalation, Dermatology, Oncology and Orthopedics.

Macleods has ambitious plans for the years ahead. The emphasis is on capitalizing market opportunities in Indian pharmaceutical market and with greater focus on the international market.